The Key to Unlocking the Chemotherapeutic Potential of PPARγLigands: Having the Right Combination
出版年份 2012 全文链接
标题
The Key to Unlocking the Chemotherapeutic Potential of PPARγLigands: Having the Right Combination
作者
关键词
-
出版物
PPAR Research
Volume 2012, Issue -, Pages 1-13
出版商
Hindawi Limited
发表日期
2012-07-04
DOI
10.1155/2012/946943
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Chemotherapeutic Drugs Induce PPAR-γ Expression and Show Sequence-Specific Synergy with PPAR-γ Ligands in Inhibition of Non–Small Cell Lung Cancer
- (2015) Raju C. Reddy et al. NEOPLASIA
- 15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways
- (2011) Yasuhiro Yamamoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs
- (2011) Florie Borel et al. HEPATOLOGY
- Synergistic Interactions between Heregulin and Peroxisome Proliferator-activated Receptor-γ (PPARγ) Agonist in Breast Cancer Cells
- (2011) Bae-Hang Park et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells
- (2010) Jorge Humberto Tapia-Pérez et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth
- (2010) Naohiko Hamaguchi et al. CANCER SCIENCE
- Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines
- (2010) Karen Bräutigam et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Cytotoxic effects of statins and thiazolidinediones on meningioma cells
- (2010) Sonja Gehring et al. JOURNAL OF NEURO-ONCOLOGY
- Regulatory Action on Rosiglitazone by the U.S. Food and Drug Administration
- (2010) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARγ signaling pathway
- (2009) Liang-qi Cao et al. ACTA PHARMACOLOGICA SINICA
- Combined Low Doses of PPARγ and RXR Ligands Trigger an Intrinsic Apoptotic Pathway in Human Breast Cancer Cells
- (2009) Daniela Bonofiglio et al. AMERICAN JOURNAL OF PATHOLOGY
- Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats
- (2009) Kulbhushan Tikoo et al. BMC CANCER
- Metallothioneins and Platinum(II) Anti-Tumor Compounds
- (2009) Markus Knipp CURRENT MEDICINAL CHEMISTRY
- PPARγ and RXRγ ligands act synergistically as potent antineoplastic agentsin vitroandin vivoglioma models
- (2009) Alessio Papi et al. JOURNAL OF NEUROCHEMISTRY
- Type II topoisomerases--inhibitors, repair mechanisms and mutations
- (2009) P. Heisig MUTAGENESIS
- Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin
- (2008) G. D. Girnun et al. CLINICAL CANCER RESEARCH
- Synergistic Effects of PPARγLigands and Retinoids in Cancer Treatment
- (2008) Masahito Shimizu et al. PPAR Research
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now